Integra LifeSciences Holdings Corporation (IART)
USD 19.49
(-2.84%)
USD 19.49
(-2.84%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 1.54 Billion USD | -1.03% |
| 2022 | 1.55 Billion USD | 0.99% |
| 2021 | 1.54 Billion USD | 12.43% |
| 2020 | 1.37 Billion USD | -9.6% |
| 2019 | 1.51 Billion USD | 3.06% |
| 2018 | 1.47 Billion USD | 23.92% |
| 2017 | 1.18 Billion USD | 19.77% |
| 2016 | 992.07 Million USD | 12.39% |
| 2015 | 882.73 Million USD | -4.91% |
| 2014 | 928.3 Million USD | 11.01% |
| 2013 | 836.21 Million USD | 0.64% |
| 2012 | 830.87 Million USD | 6.51% |
| 2011 | 780.07 Million USD | 6.56% |
| 2010 | 732.06 Million USD | 7.26% |
| 2009 | 682.48 Million USD | 4.26% |
| 2008 | 654.6 Million USD | 18.92% |
| 2007 | 550.45 Million USD | 31.28% |
| 2006 | 419.29 Million USD | 50.86% |
| 2005 | 277.93 Million USD | 20.93% |
| 2004 | 229.82 Million USD | 23.83% |
| 2003 | 185.59 Million USD | 64.79% |
| 2002 | 112.62 Million USD | 20.53% |
| 2001 | 93.44 Million USD | 43.79% |
| 2000 | 64.98 Million USD | 52.91% |
| 1999 | 42.5 Million USD | 142.86% |
| 1998 | 17.5 Million USD | 19.05% |
| 1997 | 14.7 Million USD | 12.21% |
| 1996 | 13.1 Million USD | 28.43% |
| 1995 | 10.2 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q3 | 380.83 Million USD | -8.93% |
| 2024 Q1 | 368.87 Million USD | -7.09% |
| 2024 Q2 | 418.17 Million USD | 13.37% |
| 2023 Q4 | 397.03 Million USD | 3.82% |
| 2023 Q1 | 380.84 Million USD | -4.32% |
| 2023 FY | 1.54 Billion USD | -1.03% |
| 2023 Q3 | 382.42 Million USD | 0.3% |
| 2023 Q2 | 381.26 Million USD | 0.11% |
| 2022 FY | 1.55 Billion USD | 0.99% |
| 2022 Q3 | 385.19 Million USD | -3.17% |
| 2022 Q4 | 398.02 Million USD | 3.33% |
| 2022 Q2 | 397.81 Million USD | 5.62% |
| 2022 Q1 | 376.63 Million USD | -7.12% |
| 2021 Q1 | 360.07 Million USD | -7.35% |
| 2021 Q3 | 386.86 Million USD | -0.8% |
| 2021 Q4 | 405.52 Million USD | 4.82% |
| 2021 FY | 1.54 Billion USD | 12.43% |
| 2021 Q2 | 389.99 Million USD | 8.31% |
| 2020 Q1 | 354.32 Million USD | -10.33% |
| 2020 Q3 | 370.23 Million USD | 43.13% |
| 2020 Q4 | 388.64 Million USD | 4.97% |
| 2020 FY | 1.37 Billion USD | -9.6% |
| 2020 Q2 | 258.66 Million USD | -27.0% |
| 2019 Q2 | 383.64 Million USD | 6.66% |
| 2019 Q3 | 379.09 Million USD | -1.19% |
| 2019 Q4 | 395.12 Million USD | 4.23% |
| 2019 FY | 1.51 Billion USD | 3.06% |
| 2019 Q1 | 359.69 Million USD | -6.16% |
| 2018 Q4 | 383.31 Million USD | 4.77% |
| 2018 Q2 | 366.19 Million USD | 2.55% |
| 2018 Q1 | 357.08 Million USD | -3.13% |
| 2018 FY | 1.47 Billion USD | 23.92% |
| 2018 Q3 | 365.85 Million USD | -0.09% |
| 2017 Q2 | 282.16 Million USD | 9.1% |
| 2017 Q3 | 278.83 Million USD | -1.18% |
| 2017 Q4 | 368.6 Million USD | 32.19% |
| 2017 FY | 1.18 Billion USD | 19.77% |
| 2017 Q1 | 258.63 Million USD | 1.16% |
| 2016 Q3 | 250.33 Million USD | 0.41% |
| 2016 Q4 | 255.66 Million USD | 2.13% |
| 2016 FY | 992.07 Million USD | 12.39% |
| 2016 Q2 | 249.3 Million USD | 5.3% |
| 2016 Q1 | 236.77 Million USD | -1.82% |
| 2015 Q4 | 241.16 Million USD | 6.53% |
| 2015 Q1 | 233.66 Million USD | -7.34% |
| 2015 Q2 | 244.07 Million USD | 4.46% |
| 2015 Q3 | 226.36 Million USD | -7.26% |
| 2015 FY | 882.73 Million USD | -4.91% |
| 2014 Q4 | 252.17 Million USD | 9.78% |
| 2014 Q3 | 229.71 Million USD | -0.71% |
| 2014 FY | 928.3 Million USD | 11.01% |
| 2014 Q1 | 215.05 Million USD | -2.59% |
| 2014 Q2 | 231.35 Million USD | 7.58% |
| 2013 Q2 | 205.54 Million USD | 4.52% |
| 2013 Q4 | 220.76 Million USD | 3.53% |
| 2013 FY | 836.21 Million USD | 0.64% |
| 2013 Q1 | 196.65 Million USD | -8.29% |
| 2013 Q3 | 213.24 Million USD | 3.75% |
| 2012 Q2 | 210.17 Million USD | 7.13% |
| 2012 Q3 | 210.08 Million USD | -0.04% |
| 2012 Q4 | 214.43 Million USD | 2.07% |
| 2012 FY | 830.87 Million USD | 6.51% |
| 2012 Q1 | 196.18 Million USD | -3.61% |
| 2011 Q3 | 202.18 Million USD | 4.58% |
| 2011 Q1 | 181.04 Million USD | -6.74% |
| 2011 Q2 | 193.32 Million USD | 6.79% |
| 2011 Q4 | 203.52 Million USD | 0.66% |
| 2011 FY | 780.07 Million USD | 6.56% |
| 2010 Q3 | 186.64 Million USD | 4.51% |
| 2010 Q1 | 172.69 Million USD | -5.9% |
| 2010 FY | 732.06 Million USD | 7.26% |
| 2010 Q4 | 194.13 Million USD | 4.01% |
| 2010 Q2 | 178.59 Million USD | 3.41% |
| 2009 Q4 | 183.52 Million USD | 6.52% |
| 2009 Q1 | 160.95 Million USD | -7.7% |
| 2009 Q2 | 165.72 Million USD | 2.97% |
| 2009 FY | 682.48 Million USD | 4.26% |
| 2009 Q3 | 172.28 Million USD | 3.96% |
| 2008 Q4 | 174.37 Million USD | 4.4% |
| 2008 FY | 654.6 Million USD | 18.92% |
| 2008 Q3 | 167.02 Million USD | 6.25% |
| 2008 Q2 | 157.19 Million USD | 0.76% |
| 2008 Q1 | 156 Million USD | -1.04% |
| 2007 FY | 550.45 Million USD | 31.28% |
| 2007 Q4 | 157.64 Million USD | 16.76% |
| 2007 Q3 | 135.01 Million USD | 0.18% |
| 2007 Q1 | 123.03 Million USD | -1.88% |
| 2007 Q2 | 134.76 Million USD | 9.54% |
| 2006 Q2 | 100.12 Million USD | 29.8% |
| 2006 Q3 | 116.64 Million USD | 16.51% |
| 2006 Q4 | 125.39 Million USD | 7.5% |
| 2006 FY | 419.29 Million USD | 50.86% |
| 2006 Q1 | 77.13 Million USD | 5.69% |
| 2005 FY | 277.93 Million USD | 20.93% |
| 2005 Q4 | 72.98 Million USD | 5.27% |
| 2005 Q1 | 65.83 Million USD | 6.52% |
| 2005 Q2 | 69.77 Million USD | 5.98% |
| 2005 Q3 | 69.33 Million USD | -0.64% |
| 2004 Q1 | 52.44 Million USD | -11.15% |
| 2004 Q4 | 61.81 Million USD | 4.53% |
| 2004 Q3 | 59.13 Million USD | 4.76% |
| 2004 Q2 | 56.44 Million USD | 7.62% |
| 2004 FY | 229.82 Million USD | 23.83% |
| 2003 Q1 | 36.78 Million USD | 22.34% |
| 2003 FY | 185.59 Million USD | 64.79% |
| 2003 Q4 | 59.02 Million USD | 25.43% |
| 2003 Q3 | 47.05 Million USD | 10.11% |
| 2003 Q2 | 42.73 Million USD | 16.19% |
| 2002 Q4 | 30.06 Million USD | -0.46% |
| 2002 FY | 112.62 Million USD | 20.53% |
| 2002 Q1 | 25.91 Million USD | -12.01% |
| 2002 Q2 | 26.44 Million USD | 2.03% |
| 2002 Q3 | 30.2 Million USD | 14.23% |
| 2001 FY | 93.44 Million USD | 43.79% |
| 2001 Q2 | 21.38 Million USD | -1.38% |
| 2001 Q3 | 22.31 Million USD | 4.37% |
| 2001 Q4 | 29.45 Million USD | 31.97% |
| 2001 Q1 | 21.68 Million USD | 13.07% |
| 2000 Q1 | 13.23 Million USD | 2.6% |
| 2000 Q3 | 16.89 Million USD | 7.69% |
| 2000 Q4 | 19.17 Million USD | 13.54% |
| 2000 FY | 64.98 Million USD | 52.91% |
| 2000 Q2 | 15.68 Million USD | 18.5% |
| 1999 Q1 | 5 Million USD | 4.17% |
| 1999 Q3 | 12.1 Million USD | -3.97% |
| 1999 Q4 | 12.9 Million USD | 6.61% |
| 1999 FY | 42.5 Million USD | 142.86% |
| 1999 Q2 | 12.6 Million USD | 152.0% |
| 1998 FY | 17.5 Million USD | 19.05% |
| 1998 Q3 | 4.3 Million USD | 13.16% |
| 1998 Q4 | 4.8 Million USD | 11.63% |
| 1998 Q1 | 4.6 Million USD | 39.39% |
| 1998 Q2 | 3.8 Million USD | -17.39% |
| 1997 Q2 | 4.3 Million USD | 34.38% |
| 1997 FY | 14.7 Million USD | 12.21% |
| 1997 Q4 | 3.3 Million USD | -15.38% |
| 1997 Q3 | 3.9 Million USD | -9.3% |
| 1997 Q1 | 3.2 Million USD | -15.79% |
| 1996 FY | 13.1 Million USD | 28.43% |
| 1996 Q1 | 3.1 Million USD | 3.33% |
| 1996 Q2 | 3.5 Million USD | 12.9% |
| 1996 Q3 | 2.9 Million USD | -17.14% |
| 1996 Q4 | 3.8 Million USD | 31.03% |
| 1995 Q4 | 3 Million USD | 15.38% |
| 1995 FY | 10.2 Million USD | 0.0% |
| 1995 Q3 | 2.6 Million USD | 13.04% |
| 1995 Q2 | 2.3 Million USD | 0.0% |
| 1995 Q1 | 2.3 Million USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 12.05 Million USD | -12683.589% |
| BrainsWay Ltd. | 31.78 Million USD | -4750.002% |
| Cerus Corporation | 156.36 Million USD | -885.869% |
| Envoy Medical, Inc. | 316 Thousand USD | -487739.557% |
| electroCore, Inc. | 16.03 Million USD | -9516.8% |
| Helius Medical Technologies, Inc. | 644 Thousand USD | -239274.689% |
| IceCure Medical Ltd | 3.22 Million USD | -47641.499% |
| Inogen, Inc. | 315.66 Million USD | -388.365% |
| OrthoPediatrics Corp. | 148.73 Million USD | -936.477% |
| Lucid Diagnostics Inc. | 2.42 Million USD | -63391.474% |
| Monogram Orthopaedics, Inc. | 364.99 Thousand USD | -422249.924% |
| MaxCyte, Inc. | 41.28 Million USD | -3633.707% |
| NeuroOne Medical Technologies Corporation | 1.95 Million USD | -78856.189% |
| Nexalin Technology, Inc. | 110.74 Thousand USD | -1391864.64% |
| Orthofix Medical Inc. | 746.64 Million USD | -106.468% |
| PAVmed Inc | 2.45 Million USD | -62770.024% |
| Rapid Micro Biosystems, Inc. | 22.51 Million USD | -6745.655% |
| RxSight, Inc. | 89.07 Million USD | -1630.607% |
| Sight Sciences, Inc. | 81.05 Million USD | -1801.862% |
| SI-BONE, Inc. | 138.88 Million USD | -1009.956% |
| TELA Bio, Inc. | 58.45 Million USD | -2537.286% |
| Treace Medical Concepts, Inc. | 187.11 Million USD | -723.851% |
| Vivos Therapeutics, Inc. | 13.8 Million USD | -11070.009% |
| Acutus Medical, Inc. | 7.16 Million USD | -21418.328% |
| Talis Biomedical Corporation | 412 Thousand USD | -374068.204% |
| Spectral AI, Inc. | 18.05 Million USD | -8437.733% |
| Nano-X Imaging Ltd. | 9.9 Million USD | -15463.584% |
| CVRx, Inc. | 39.29 Million USD | -3823.077% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 968.7 Thousand USD | -159037.344% |
| Bioventus Inc. | 512.34 Million USD | -200.886% |
| Venus Concept Inc. | 76.35 Million USD | -1918.981% |
| TriSalus Life Sciences, Inc. | 18.51 Million USD | -8227.875% |
| LivaNova PLC | 1.15 Billion USD | -33.638% |
| 908 Devices Inc. | 50.22 Million USD | -2969.09% |
| Alphatec Holdings, Inc. | 482.26 Million USD | -219.655% |
| Nemaura Medical Inc. | 77.04 Thousand USD | -2000799.486% |
| NeuroPace, Inc. | 65.42 Million USD | -2256.389% |
| LENSAR, Inc. | 42.16 Million USD | -3556.136% |
| Apyx Medical Corporation | 52.34 Million USD | -2844.799% |
| Cutera, Inc. | 212.36 Million USD | -625.894% |
| STRATA Skin Sciences, Inc. | 33.35 Million USD | -4521.299% |
| BioSig Technologies, Inc. | 18 Thousand USD | -8564194.444% |
| Anika Therapeutics, Inc. | 166.66 Million USD | -824.97% |
| ClearPoint Neuro, Inc. | 23.95 Million USD | -6335.287% |
| Axonics, Inc. | 366.37 Million USD | -320.759% |
| Outset Medical, Inc. | 130.37 Million USD | -1082.406% |
| IRIDEX Corporation | 51.86 Million USD | -2872.051% |
| PROCEPT BioRobotics Corporation | 136.19 Million USD | -1031.92% |
| IRadimed Corporation | 65.56 Million USD | -2251.31% |
| Tivic Health Systems, Inc. | 1.17 Million USD | -130986.139% |
| INVO Bioscience, Inc. | 3.02 Million USD | -50935.747% |
| Telesis Bio, Inc. | 27.5 Million USD | -5503.886% |
| Viemed Healthcare, Inc. | 183 Million USD | -742.353% |
| Varex Imaging Corporation | 811 Million USD | -90.083% |
| Quipt Home Medical Corp. | 221.74 Million USD | -595.21% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Pulmonx Corporation | 68.67 Million USD | -2144.737% |
| Dynatronics Corporation | 32.53 Million USD | -4638.35% |
| Modular Medical, Inc. | - USD | -Infinity% |
| ReShape Lifesciences Inc. | 8.67 Million USD | -17664.151% |
| Semler Scientific, Inc. | 68.18 Million USD | -2160.901% |
| InMode Ltd. | 492.04 Million USD | -213.297% |
| Bruker Corporation | 2.96 Billion USD | 47.999% |
| Cytosorbents Corporation | 36.34 Million USD | -4140.989% |
| DexCom, Inc. | 3.62 Billion USD | 57.442% |
| Align Technology, Inc. | 3.86 Billion USD | 60.086% |
| Viveve Medical, Inc. | 6.42 Million USD | -23889.62% |
| ZimVie Inc. | 457.43 Million USD | -237.005% |
| Movano Inc. | - USD | -Infinity% |
| Cytek Biosciences, Inc. | 193.01 Million USD | -698.68% |
| Nexalin Technology, Inc. | 110.74 Thousand USD | -1391864.64% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 747.71 Million USD | -106.17% |
| Profound Medical Corp. | 7.33 Million USD | -20928.081% |
| Insulet Corporation | 1.69 Billion USD | 9.164% |
| enVVeno Medical Corporation | - USD | -Infinity% |
| Surmodics, Inc. | 126.07 Million USD | -1122.714% |
| iCAD, Inc. | 17.31 Million USD | -8801.565% |
| Nuwellis, Inc. | 8.86 Million USD | -17291.392% |
| Biotricity, Inc. | 12.06 Million USD | -12678.985% |
| iRhythm Technologies, Inc. | 492.68 Million USD | -212.895% |
| Aethlon Medical, Inc. | - USD | -Infinity% |
| InspireMD, Inc. | 6.2 Million USD | -24744.045% |
| PAVmed Inc. | 2.45 Million USD | -62770.024% |
| BIOLASE, Inc. | 49.16 Million USD | -3035.573% |
| Beyond Air, Inc. | 1.15 Million USD | -132908.887% |
| FONAR Corporation | 102.88 Million USD | -1398.359% |
| AxoGen, Inc. | 159.01 Million USD | -869.47% |
| Vivani Medical, Inc. | - USD | -Infinity% |
| Tactile Systems Technology, Inc. | 274.42 Million USD | -461.751% |
| Inari Medical, Inc. | 493.63 Million USD | -212.292% |
| UFP Technologies, Inc. | 400.07 Million USD | -285.324% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 18.6 Thousand USD | -8287926.882% |
| Tenon Medical, Inc. | 2.92 Million USD | -52549.351% |
| Autonomix Medical, Inc. Common Stock | - USD | -Infinity% |
| Co-Diagnostics, Inc. | 6.81 Million USD | -22530.129% |
| AdaptHealth Corp. | 3.2 Billion USD | 51.829% |
| Sintx Technologies, Inc. | 2.62 Million USD | -58581.88% |
| NanoVibronix, Inc. | 2.28 Million USD | -67424.004% |
| Quanterix Corporation | 122.36 Million USD | -1159.784% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Sensus Healthcare, Inc. | 24.4 Million USD | -6216.628% |
| Pacific Biosciences of California, Inc. | 200.52 Million USD | -668.784% |
| TransMedics Group, Inc. | 241.62 Million USD | -538.008% |
| ReWalk Robotics Ltd. | 13.85 Million USD | -11027.277% |
| NeuroMetrix, Inc. | 5.9 Million USD | -26022.047% |
| Hyperfine, Inc. | 11.03 Million USD | -13873.649% |
| Establishment Labs Holdings Inc. | 165.15 Million USD | -833.432% |
| Biomerica, Inc. | 5.41 Million USD | -28368.569% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 50.56 Million USD | -2948.937% |
| Bluejay Diagnostics, Inc. | - USD | -Infinity% |
| Silk Road Medical, Inc | 177.13 Million USD | -770.286% |